SCHEMBL24318167

SCHEMBL24318167

Cc1ccc(Nc2ccc(Nc3ccccc3)cc2)c(C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.55
NPSR1 Q6W5P4 1/20 0.50
NPC1 O15118 2/20 0.45
RAB9A P51151 1/20 0.45
GAA P10253 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
HSD17B10 Q99714 3/20 0.43
ALDH1A1 P00352 3/20 0.43
ALOX15 P16050 2/20 0.43
TSHR P16473 2/20 0.43
ALOX12 P18054 2/20 0.43
PTGS1 P23219 1/20 0.43
SLC6A2 P23975 1/20 0.43
MAPK1 P28482 1/20 0.43
PTGS2 P35354 1/20 0.43
HTR2B P41595 1/20 0.43
CXCR2 P25025 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24318168 0.83 ALDH1A1 (0.44) HPGDNPSR1RAB9AGAAMEN1
SCHEMBL19626178 0.83 CXCR2 (0.47) HPGDNPSR1NPC1RAB9AGAA
SCHEMBL8962199 0.76 TDP1 (0.50) HPGDNPC1RAB9AGAAMEN1
SCHEMBL429859 0.74 GAA (0.62) HPGDNPSR1NPC1RAB9AGAA
SCHEMBL29473561 0.74 GAA (0.62) HPGDNPSR1NPC1RAB9AGAA
SCHEMBL8691617 0.74 RAPGEF4 (0.57) HPGDNPSR1NPC1RAB9AGAA
SCHEMBL1029810 0.74 ALDH1A1 (0.51) HPGDNPSR1GAAMEN1KMT2A
SCHEMBL30514613 0.74 HPGD (0.67) HPGDNPSR1NPC1RAB9AGAA
SCHEMBL9461706 0.73 HPGD (1.00) HPGDNPSR1NPC1RAB9AGAA
SCHEMBL24137168 0.73 HPGD (1.00) HPGDNPSR1NPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048565-A1 PREPARATION METHOD FOR ASYMMETRIC DIARYL SUBSTITUTED P-PHENYLENEDIAMINE COMPOUND 圣奥化学科技有限公司 2022-03-10 WO disclosed